Healthy women with an evening chronotype—individuals who naturally prefer later sleep and meal times—show higher body fat percentages and less favorable metabolic markers compared to those with morning or intermediate preferences, according to a study published in Frontiers in Nutrition. Research from the PROMISE study indicates that meal timing, particularly the consumption of energy late … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
Metabolic dysfunction-associated steatotic liver disease (MASLD) may affect up to 47% of adults in Mexico, according to a review published in Archives of Medical Research. Lead author Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy, argues that Mexico must integrate liver health into existing obesity and diabetes programs … Read more
Obesity May Fuel Leukemia Growth, Study Reveals Obesity may act as a catalyst for leukemia progression, according to a study led by Indiana University School of Medicine researchers. Published in the Journal of Clinical Investigation, the findings suggest that chronic inflammation linked to obesity creates an environment where leukemia cells thrive. The work, conducted by … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
New research suggests that the cardiovascular health benefits of semaglutide may be more closely tied to the drug’s dosage than to the amount of weight a patient loses. A retrospective study published in npj Cardiovascular Health found that patients reaching higher maximum doses of semaglutide—1.7 mg or greater—experienced significantly lower risks of heart failure, cerebrovascular … Read more
Evening chronotypes, or “night owls,” face higher risks of obesity and metabolic dysfunction due to a tendency to consume high-calorie, high-fat foods late at night, according to research from Griffith University. Professor Rozanne Kruger found that meal timing, rather than total caloric intake, correlates with increased body fat and poorer glucose regulation in women. How … Read more
A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more
Average total testosterone levels in men dropped by 54 percent between 1972 and 2019, according to a multi-country analysis presented at the European Society of Human Reproduction and Embryology. Led by Prof. Hagai Levine of the Hebrew University-Hadassah Braun School of Public Health and Community Medicine, the research synthesized six longitudinal studies involving 118,593 men … Read more
Medicare prescriptions for the anti-obesity medication Wegovy surged 598% in the six months following a federal policy shift that allowed coverage for heart disease prevention. Despite this increase, new research from the USC Schaeffer Center for Health Policy & Economics reveals that less than 1% of the estimated 3.6 million eligible beneficiaries have accessed the … Read more